Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Author:
Funder
National Center for Advancing Translational Sciences
National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Molecular Biology,Molecular Medicine
Reference135 articles.
1. Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 M(pro) and spike protein: drug repurposing approach;Abosheasha;Drug Dev. Res.,2021
2. Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort study;Abu Esba;Infect. Dis. Ther.,2021
3. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial;Angus;Jama,2020
4. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients;Archambault;Faseb. J. : official publication of the Federation of American Societies for Experimental Biology,2021
5. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis;Auphan;Science,1995
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk Factors and Nomogram Prediction Model for Healthcare-Associated Infections (HAIs) in COVID-19 Patients;Infection and Drug Resistance;2024-08
2. Comparison of safety of acetaminophen and ibuprofen in minors: based on the FAERS database;Expert Opinion on Drug Safety;2024-05-12
3. Aspects of pharmacotherapy with steroids in SARS-CoV-2 infection (literature review);Experimental and Clinical Medicine;2024-03-31
4. Novel Insight into the Cellular and Molecular Signaling Pathways of Costus speciosus in the Treatment of COVID-19: A Review;Nature Cell and Science;2024-03-30
5. CLINICAL AND PHARMACOLOGICAL ASPECTS OF APPLYING GLUCOCORTICOSTEROIDS FOR SARS-COVID-2 INFECTION: REVIEW ARTICLE;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2024-03-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3